Nebula Research & Development LLC Care Dx, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 33,180 shares of CDNA stock, worth $641,037. This represents 0.08% of its overall portfolio holdings.
Number of Shares
33,180
Previous 36,345
8.71%
Holding current value
$641,037
Previous $1.13 Billion
37.4%
% of portfolio
0.08%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding CDNA
# of Institutions
217Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$93.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$51.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$46.5 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$42.6 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.03B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...